Modeling and Artificial Intelligence (AI) in Generic Drug Development and Product Lifecycle Management: Regulatory Insights and Future Trends

Date and Time: October 15 , 8:30 am – 5:10 pm , October 16 , 8:30 am – 3:40 pm Co-hosts: FDA and the Center for Research on Complex Generics (CRCG) https://www.complexgenerics.org/education-training/modeling-and-artificial-intelligence-ai-in-generic-drugs-regulatory-insights-and-future-trends/?utm_medium=email&utm_source=govdelivery Artificial Intelligence (AI) is rapidly transforming drug development and regulatory processes across the pharmaceutical industry. This workshop explores cutting-edge applications of modeling and AI throughout the drug development lifecycle, with particular emphasis on complex generics. Through presentations, panel discussions, and interactive sessions, attendees will examine how AI is being integrated into regulatory frameworks to streamline workflows, accelerate development timelines, and advance quantitative medicine approaches.